SULLIVAN LOUIS W — SEC Form 4 filings
SEC reporting owner CIK 1193522. 9 Form 4 filings on record with FilingPulse; latest filed 2026-07-23.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-05-06 to 2026-07-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 28 legs across 3 filings — 37,319 shares, $14,162,200 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 22.
- Largest priced transaction: sale of 4,863 shares @ $512.34 ($2,491,501) in UNITED THERAPEUTICS Corp, filed 2025-12-23.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | Director | 7 | — | 28 legs · 37,319 sh · $14,162,200 | 18 |
| Emergent BioSolutions Inc. (EBS) | Director | 2 | — | — | 4 |
Form 4 filings — SULLIVAN LOUIS W
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-23 | 4 | UNITED THERAPEUTICS Corp (UTHR) | Grant/award (A): 2,380 (derivative) @ $0 | EDGAR |
| 2026-07-13 | 4 | UNITED THERAPEUTICS Corp (UTHR) | Option exercise (M): 650 @ $0 · Option exercise (M): 650 (derivative) @ $0 | EDGAR |
| 2025-12-23 | 4 | UNITED THERAPEUTICS Corp (UTHR) | Option exercise (M): 3,230 @ $183.98 · Option exercise (M): 2,720 @ $229.81 · Sale (S): 1,087 @ $511.22 · Sale (S): 4,863 @ $512.34 · Option exercise (M): 3,230 (derivative) @ $0 · Option exercise (M): 2,720 (derivative) @ $0 | EDGAR |
| 2025-07-28 | 4 | UNITED THERAPEUTICS Corp (UTHR) | Option exercise (M): 590 @ $0 · Option exercise (M): 590 (derivative) @ $0 · Grant/award (A): 650 (derivative) @ $0 · Grant/award (A): 1,830 (derivative) @ $0 | EDGAR |
| 2025-05-02 | 4 | Emergent BioSolutions Inc. (EBS) | Grant/award (A): 34,403 @ $0 · Grant/award (A): 15,824 (derivative) @ $0 | EDGAR |
| 2024-12-19 | 4 | UNITED THERAPEUTICS Corp (UTHR) | Option exercise (M): 15,000 @ $175.43 · Sale (S): 1,121 @ $366.11 · Sale (S): 600 @ $366.97 · Sale (S): 1,307 @ $368.50 · Sale (S): 2,100 @ $369.32 · Sale (S): 1,400 @ $370.30 · +21 more | EDGAR |
| 2024-07-26 | 4 | UNITED THERAPEUTICS Corp (UTHR) | Grant/award (A): 1,440 (derivative) @ $0 · Grant/award (A): 590 (derivative) @ $0 | EDGAR |
| 2024-05-28 | 4 | Emergent BioSolutions Inc. (EBS) | Grant/award (A): 17,430 @ $0 · Grant/award (A): 25,748 (derivative) @ $0 | EDGAR |
| 2024-05-06 | 4 | UNITED THERAPEUTICS Corp (UTHR) | Option exercise (M): 5,160 @ $119.76 · Sale (S): 2,181 @ $257.39 · Sale (S): 2,979 @ $259.12 · Option exercise (M): 5,160 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1193522 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →